TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 53 filers reported holding TRANSLATE BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,327,000 | -17.7% | 48,208 | -50.7% | 0.00% | 0.0% |
| Q1 2021 | $1,613,000 | -62.5% | 97,795 | -58.1% | 0.00% | -50.0% |
| Q4 2020 | $4,299,000 | +332.5% | 233,200 | +219.3% | 0.00% | +100.0% |
| Q3 2020 | $994,000 | +17.4% | 73,039 | +54.6% | 0.00% | 0.0% |
| Q2 2020 | $847,000 | +636.5% | 47,248 | +310.8% | 0.00% | – |
| Q1 2020 | $115,000 | -64.5% | 11,502 | -71.1% | 0.00% | – |
| Q4 2019 | $324,000 | +77.0% | 39,829 | +115.1% | 0.00% | – |
| Q3 2019 | $183,000 | -23.4% | 18,513 | -2.2% | 0.00% | – |
| Q2 2019 | $239,000 | +165.6% | 18,938 | +114.0% | 0.00% | – |
| Q1 2019 | $90,000 | +80.0% | 8,848 | +31.9% | 0.00% | – |
| Q4 2018 | $50,000 | +35.1% | 6,710 | +82.8% | 0.00% | – |
| Q3 2018 | $37,000 | – | 3,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,437,601 | $24,376,000 | 11.53% |
| DAFNA Capital Management LLC | 151,739 | $1,517,000 | 0.62% |
| Bain Capital Public Equity Management, LLC | 738,543 | $7,385,000 | 0.52% |
| Baupost Group | 6,491,287 | $62,393,000 | 0.48% |
| Rock Springs Capital Management LP | 1,009,179 | $10,092,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 276,639 | $2,766,000 | 0.32% |
| Cormorant Asset Management, LP | 454,550 | $4,546,000 | 0.30% |
| Artal Group S.A. | 600,000 | $6,000,000 | 0.16% |
| Perceptive Advisors | 500,000 | $5,000,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 367,744 | $3,677,000 | 0.03% |